IP Library Granted Patent US 8,740,987
Granted Patent B2
US 8,740,987 · App. 11/018,853 · Granted Jun 3, 2014

Tissue-derived mesh for orthopedic regeneration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,740,987
App. No.
11/018,853
Granted
Jun 3, 2014
Kind
B2
Abstract

An implant including a substantially cohesive aggregate comprising bone-derived particles. Cohesiveness is maintained by a member of mechanical interlocking, engagement of adjacent bone-derived particles with one another through engagement with a binding agent, thermal bonding, chemical bonding, or a matrix material in which the bone-derived particles are retained. The aggregate is shaped as a one-dimensional or two-dimensional body.

Claims (11)

1. An implant comprising a flexible porous gauze woven from a plurality of cohesive aggregate strands, each of the cohesive aggregate strands comprising bone particles and a gene activated matrix, and the bone particles of each strand are retained in a polymer matrix, the polymer matrix having a particle width from about 0.05 mm to about 150 mm.

2. The implant of claim 1 , wherein the polymer matrix is or comprises polyurethane.

3. The implant of claim 1 , wherein the gauze is woven from the plurality of cohesive aggregate strands in the form of a braid.

4. The implant of claim 1 , wherein the polymer matrix is or comprises a polylactide, poly(L-lactide-co-DL-lactide), or tyrosine-based polycarbonate.

5. The implant of claim 1 , wherein the porous gauze retains an agent; the agent being selected from the group consisting of trophic factors, adhesives, plasticizers, therapeutic agents, biostatic agents, biocidal agents, bioactive agents, biomolecules, small molecules, and any combinations of the above.

6. The implant of claim 1 , wherein the implant further comprises a substrate on which the gauze is coated.

7. The implant of claim 6 , wherein the substrate has a shape selected from the group consisting of a member of a bone, sponge, cone, portion of cone, tube, particle, rod, sphere, strand, coiled strand, capillary network, film, fiber, mesh, sheet, threaded cylinder, rod, hinge, rivet, anchor, spheroid, ellipsoid, oblate spheroid, prolate ellipsoid, hyperbolic paraboloid and bulk implant.

8. The implant of claim 1 , further comprising cells selected from the group consisting of connective tissue cells, organ cells, muscle cells, nerve cells, and stem cells.

9. The implant of claim 8 , wherein the cells are selected from the group consisting of osteoblasts, osteoclasts, tenocytes, fibroblasts, chondrocytes, ligament cells, and mesenchymal stem cells.

10. The implant of claim 1 , further comprising a permanent implant about at least a portion of which the gauze is wrapped.

11. The implant of claim 1 , wherein the implant is a composite comprising the gauze and a second material, wherein the second material is selected from the group consisting of a hydrogel, a ceramic, a metal, a natural polymer, a synthetic, recombinant, or modified version of a natural polymer, and a synthetic polymer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2011
From: OSTEOTECH, INC.
To: WARSAW ORTHOPEDIC, INC.
Reel/Frame 026196/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2007
From: GEREMAKIS, PERRY; GRASSO, JENNIFER; KNAACK, DAVID; SHIMP, LAWRENCE; WINTERBOTTOM, JOHN
To: OSTEOTECH, INC.
Reel/Frame 019376/0049 →